| PubMed:Comparative bio-safety and in vivo evaluation of native or modified locust bean gum-PVA IPN microspheres. | 
| PubMed:Huoxue Rongluo Tablet reduces matrix metalloproteinase-9 expression in infarcted brain tissue. | 
| PubMed:Combined study of biphasic and zero-order release formulations with dissolution tests and ATR-FTIR spectroscopic imaging. | 
| PubMed:Microwave assisted synthesis of acrylamide grafted locust bean gum and its application in drug delivery. | 
| PubMed:Application of a high performance liquid chromatography-tandem mass spectrometry method for determination of buflomedil in human plasma for a bioequivalence study. | 
| PubMed:Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery. | 
| PubMed:Buflomedil for intermittent claudication. | 
| PubMed:[Long-term functional outcomes of digital ischemia under tourniquet: observations in three cases]. | 
| PubMed:Vasoactive agent buflomedil up-regulated expression of vascular endothelial growth factor in a rat model of sciatic nerve crush injury. | 
| PubMed:[Microbial transformation of buflomedil by Cunninghamella blakesleana AS 3.153]. | 
| PubMed:Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. | 
| PubMed:Oral vasodilators for primary Raynaud's phenomenon. | 
| PubMed:The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study. | 
| PubMed:Safety of subcutaneous microinjections (mesotherapy) in musicians. | 
| PubMed:Buflomedil: still too many fatal cardiac and neurological events. | 
| PubMed:Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes. | 
| PubMed:Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy. | 
| PubMed:A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. | 
| PubMed:Influence of pharmacological treatment on blood flow and muscle perfusion in patients with obliterative atheromatosis assessed with isotopic methods. A pilot study. | 
| PubMed:Quantification of the Vasoactive Agent Buflomedil HCl in Pharmaceutical Formulation and Human Serum by Stripping Voltammetry and Liquid Chromatography. | 
| PubMed:[Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases]. | 
| PubMed:[Multicentric study of thrombosis prevention in upper-extremity microsurgery. Survey at the Fesum centers]. | 
| PubMed:Effects of buflomedil and pentoxifylline on hamster skin-flap microcirculation: prediction of flap viability using orthogonal polarization spectral imaging. | 
| PubMed:Effectiveness of interventions of specific complaints of the arm, neck, or shoulder (CANS): musculoskeletal disorders of the hand. | 
| PubMed:Silence of the limbs pharmacological symptomatic treatment of intermittent claudication. | 
| PubMed:Pharmacologic therapy for intermittent claudication. | 
| PubMed:Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication. | 
| PubMed:Cutaneous granulomatous reaction from mesotherapy. | 
| PubMed:Buflomedil: potential new indications for an old agent. | 
| PubMed:Buflomedil reduced cardiovascular events in peripheral arterial disease. | 
| PubMed:Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study". | 
| PubMed:Oral vasodilators for primary Raynaud's phenomenon. | 
| PubMed:Effectiveness of mesotherapy on body contouring. | 
| PubMed:Buflomedil in peripheral arterial disease: trials and tribulations. | 
| PubMed:Buflomedil for intermittent claudication. | 
| PubMed:Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. | 
| PubMed:The use of buflomedil in reduction mammaplasty for a previously irradiated breast: a case report. | 
| PubMed:Long-term follow-up of hypothenar hammer syndrome: a series of 47 patients. | 
| PubMed:Buflomedil for intermittent claudication. | 
| PubMed:Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release. | 
| PubMed:Sensitive and rapid LC-ESI-MS method for the determination of trimetazidine in human plasma. | 
| PubMed:Detailed documentation of one lipolysis treatment: blood values, histology, and ultrasound findings. | 
| PubMed:Buflomedil: still seizures and cardiac disorders. Too many patients are exposed to an unjustified risk of serious adverse effects. | 
| PubMed:[Adenosine for treatment of ischemic pain in thromboangiitis obliterans. A case report]. | 
| PubMed:The effects of prostaglandin E-1 in patients with intermittent claudication. | 
| PubMed:Buflomedil and pentoxifylline in the viability of dorsal cutaneous flaps of rats treated with nicotine. | 
| PubMed:Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis. | 
| PubMed:Assemblage of novel release modules for the development of adaptable drug delivery systems. | 
| PubMed:[Severe peripheral ischemia of rare origin]. | 
| PubMed:Facilitated column selection in pharmaceutical analyses using a simple column classification system. | 
| PubMed:[Pharmaceutical analysis and validation of hospital prescriptions, a 5-year study]. | 
| PubMed:Protective effect of buflomedil in a rat model of moderate cerebral ischemia. | 
| PubMed:Effect of loading on a swelling-controlled drug delivery system studied by optical techniques. | 
| PubMed:Continuous peripheral nerve blocks at home for treatment of recurrent complex regional pain syndrome I in children. | 
| PubMed:Does Danshen improve disability after acute ischaemic stroke? | 
| PubMed:Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat. | 
| PubMed:[Pharmacokinetics and bioequivalence of eperisone hydrochloride tablet in healthy subjects]. | 
| PubMed:Suicide by buflomedil HCl: a case report. | 
| PubMed:Drug treatment of intermittent claudication. | 
| PubMed:[Secondary prevention and conservative therapy of obliterative arteriosclerosis]. | 
| PubMed:Rapid and sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the determination of eperisone in human plasma: method and clinical applications. | 
| PubMed:[Suicidal buflomedil intoxication]. | 
| PubMed:Development of pulsatile release tablets with swelling and rupturable layers. | 
| PubMed:Effects of PGE-1 in patients suffering from peripheral arterial occlusive disease. | 
| PubMed:[Sudden hearing loss. Clinical case]. | 
| PubMed:[Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients]. | 
| PubMed:Rapid HPLC measurement of buflomedil in plasma in poisoning cases. | 
| PubMed:Rheological and biochemical examination of red blood cells after treatment with different pharmacological and toxic substances. | 
| PubMed:Highlights of the 22nd French pharmacovigilance meeting. | 
| PubMed:[Bullous pemphigoid induced by spironolactone]. | 
| PubMed:Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication. | 
| PubMed:[Retrograde venous perfusion (RVP in ulcero-mutilating neuropathy]. | 
| PubMed:Effects of buflomedil on early carotid atherosclerosis in Type 2 diabetic patients. | 
| PubMed:[Myoclonic coma and severe cardiac insufficiency in a patient with arteritis]. | 
| PubMed:Buflomedil for intermittent claudication. | 
| PubMed:Heparin protects local skin microcirculation in 210 minutes-long intravital microscopy observations under general anaesthesia. | 
| PubMed:Adenosine and chronic ischemia of the lower limbs. | 
| PubMed:Buflomedil poisoning: a potentially life-threatening intoxication. | 
| PubMed:Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. | 
| PubMed:[Morphometric analysis of erythrocyte aggregates in vitro: pharmacological application with buflomedil]. | 
| PubMed:Oral vasoactive medication in intermittent claudication: utile or futile? | 
| PubMed:Warning! One buflomedil may hide another one! | 
| PubMed:Assessment of collateral perfusion: a pharmacodynamic study with buflomedil hydrochloride. | 
| PubMed:Tissular oxygenation and venoarteriolar reflex disturbances in diabetes mellitus: vasoregulator effect of Buflomedil. | 
| PubMed:[Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease]. | 
| PubMed:Acceleration of wound healing by topical drug delivery via liposomes. | 
| PubMed:[Fatal poisoning caused by buflomedil]. | 
| PubMed:Nitrite plasma levels in normolipemic and hypercholesterolemic arteriopathics after vasoactive and lipid-lowering treatment. | 
| PubMed:Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethyl cellulose matrices containing a soluble drug. | 
| PubMed:Effects of prostaglandin E1 and buflomedil on left ventricular function in patients with severe chronic occlusive arterial disease: a prospective, randomized, double-blind trial. | 
| PubMed:Anaphylactic reactions to buflomedil. | 
| PubMed:[Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?]. | 
| PubMed:[Third degree atrio-ventricular block induced by interferon alpha. Report of a case]. | 
| PubMed:Buflomedil hydrochloride reduces systemic activation of polymorphonuclear leukocytes during hyperdynamic endotoxemia. | 
| PubMed:Reduction of skin flap necrosis by transdermal application of buflomedil bound to liposomes. | 
| PubMed:Multicriteria decision analysis for determining drug therapy for intermittent claudication. | 
| PubMed:Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. | 
| PubMed:[Intermittent claudication: review of a disease of growing prevalence. II. Treatment]. | 
| PubMed:A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication. | 
| PubMed:Differential modulation of IL-8 and TNF-alpha expression in human keratinocytes by buflomedil chlorhydrate and pentoxifylline. | 
| PubMed:Effects of a calcium antagonist and of the adrenergic system on spontaneous vasomotion and mean arteriolar diameter in the hamster cheek pouch: influence of buflomedil. | 
| PubMed:State of the art--treatment of peripheral occlusive arterial disease (POAD) with drugs vs. vascular reconstruction or amputation. | 
| PubMed:Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. | 
| PubMed:Pharmacological preconditioning of ischaemia. | 
| PubMed:Effect of buflomedil on the neutrophil-endothelial cell interaction under inflammatory and hypoxia conditions. | 
| PubMed:Failure of buflomedil to improve wound healing in ischaemic skin flaps. | 
| PubMed:Dialysis clearance of buflomedil in hemodialysed patients. | 
| PubMed:Buflomedil poisoning: five cases with cardiotoxicity. | 
| PubMed:Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. | 
| PubMed:Drug diffusion front movement is important in drug release control from swellable matrix tablets. | 
| PubMed:[Severe intoxications by buflomedil. 2 cases]. | 
| PubMed:The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants. | 
| PubMed:[Disordered cutaneous microcirculation in diabetic neuropathic foot ulcer. Is modification by retrograde transvenous perfusion therapy possible?]. | 
| PubMed:[Physicochemical incompatibility of injectable drugs: practical considerations]. | 
| PubMed:Acute buflomedil intoxication: a critically life-threatening condition. | 
| PubMed:[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination]. | 
| PubMed:A fatal case of buflomedil self-poisoning: toxicological data and literature review. | 
| PubMed:The early effects of intravenous L-propionyl carnitine on ulcerative trophic lesions of the lower limbs in arteriopathic patients: a controlled randomized study. | 
| PubMed:[Severe acute buflomedil poisoning]. | 
| PubMed:A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication. | 
| PubMed:Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans. | 
| PubMed:[Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial]. | 
| PubMed:[Effects of buflomedil and naftidrofuryl on the human cochlear microcirculation measured by laser-Doppler]. | 
| PubMed:The use of buflomedil in peripheral angiography. | 
| PubMed:Visualization of nutritive perfusion following tourniquet ischemia in arterial pattern skin flaps: effect of vasoactive medication. | 
| PubMed:Effects of buflomedil on spontaneous vasomotion and mean arteriolar internal diameter in the hamster cheek pouch. | 
| PubMed:Buflomedil hydrochloride attenuates tourniquet-induced microvascular reperfusion injury in striated muscle. | 
| PubMed:Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs. | 
| PubMed:Disturbances of cutaneous microcirculation in patients with diabetic legs: additional parameters for a new therapeutic concept? | 
| PubMed:Evaluation of two buflomedil tablet formulations in patients with atherosclerotic disease. | 
| PubMed:[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura]. | 
| PubMed:[Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs]. | 
| PubMed:Acute buflomedil intoxication: a life-threatening condition. | 
| PubMed:[Can vasomotion be modified by vasoactive substances or hemodilution?]. | 
| PubMed:[Value of buflomedil in vascular radiology of hepatoma]. | 
| PubMed:Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment. | 
| PubMed:Optimization of distal artery opacification in peripheral arteriography: comparison between nitroglycerin, tolazoline and buflomedyl. | 
| PubMed:Effect of buflomedil on in vitro prostacyclin and endothelin synthesis by vascular (rat and human) and penile (rat) tissue and calcium uptake by isolated human platelets. | 
| PubMed:Treatment of the Raynaud's phenomenon with piracetam. | 
| PubMed:Buflomedil: one-year oral safety evaluation in rats. | 
| PubMed:Impact of ischemia on tissue oxygenation and wound healing: intravital microscopic studies on the hairless mouse ear model. | 
| PubMed:[Nuclear medicine studies of tissue concentration and hemodynamic effects of retrograde intravenous pressure infusions]. | 
| PubMed:[Systemic infusion therapy versus retrograde intravenous perfusion: comparative results in patients with diabetic neuropathic plantar ulcer]. | 
| PubMed:[Pioneer experience with buflomedil in the form of retrograde venous pulse therapy for treatment of ischemia and severe extremity infections]. | 
| PubMed:[Status epilepticus following voluntary poisoning with buflomedil]. | 
| PubMed:Walk training and drug treatment in patients with peripheral arterial occlusive disease stage II. A review. | 
| PubMed:Vascular manifestations in homocystinuria. | 
| PubMed:The effect of oral buflomedil on microalbuminuria in non-insulin-dependent diabetic patients. | 
| PubMed:Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers. | 
| PubMed:Pretreatment with buflomedil enhances ventricular function by reducing the dysfunctional area after transient coronary artery occlusion. | 
| PubMed:Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin. | 
| PubMed:[Use of vasoactive substances in prevention of skin necroses]. | 
| PubMed:[Poisoning by buflomedil (Fonzylane)]. | 
| PubMed:Buflomedil intoxication: the little-known risk. | 
| PubMed:Effect of intensive walking exercise on skeletal muscle blood flow in intermittent claudication. | 
| PubMed:Impact of ischemia on tissue oxygenation and wound healing: improvement by vasoactive medication. | 
| PubMed:[Fatal suicide by buflomedil poisoning]. | 
| PubMed:Gas chromatographic-mass spectrometric analysis of buflomedil hydrochloride in biological samples after acute intoxication. | 
| PubMed:Vasodilator and angioprotective activity of 1-ethyl-1-hydroxyalkyl-octahydroindolo[2,3a]quinolizine derivates. | 
| PubMed:Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up. | 
| PubMed:Increase in skin-flap survival by the vasoactive drug buflomedil. | 
| PubMed:Effects of buflomedil on microvascular disorders in diabetic patients. | 
| PubMed:Exercise-induced variations in muscle tissue oxygen pressure in claudicants: effects of buflomedil. | 
| PubMed:Microvascular motricity and haemorheology effects of buflomedil. Symposium held during the International Congress on Angiology. Rome, September 21, 1989. Proceedings. | 
| PubMed:Rheological activity of propionyl L-carnitine. | 
| PubMed:Drug therapy of diabetic neuropathic foot ulcers: transvenous retrograde perfusion versus systemic regimen. | 
| PubMed:[Possibilities and limits of physical training therapy of intermittent claudication patients with simultaneous drug therapy]. | 
| PubMed:[Retrograde venous perfusion in treatment of diabetic gangrene]. | 
| PubMed:Effect of buflomedil, dipyridamole and indobufene on hemorrheologic and blood coagulation parameters in patients who underwent vascular surgery for severe atherosclerosis. | 
| PubMed:Reduction of postischemic reperfusion injury by the vasoactive drug buflomedil. | 
| PubMed:Norepinephrine, phentolamine and buflomedil influence on arteriolar vasomotion in the hamster skinfold preparation. | 
| PubMed:Hemorheological effects of buflomedil: action on shape and functions of the human neutrophils. | 
| PubMed:[Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study]. | 
| PubMed:High-performance liquid chromatographic method for the measurement of buflomedil in plasma and serum. | 
| PubMed:[Cerebral vasodilators]. | 
| PubMed:[Local application of buflomedil. Value in the treatment of subcutaneous tissue loss]. | 
| PubMed:A review of long-term safety data with buflomedil. | 
| PubMed:Effects of torbafylline, pentoxifylline and buflomedil on vascularisation and fibre type of rat skeletal muscles subjected to limited blood supply. | 
| PubMed:Effects of buflomedil and its two derivatives, CRL40634 and CRL40598, on pancreatic exocrine secretion in the rat. | 
| PubMed:[Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication]. | 
| PubMed:Current therapy of peripheral obstructive arterial disease. The non-surgical approach. | 
| PubMed:Quantitation and ultraviolet spectrum identification of buflomedil in whole blood and plasma by HPLC. | 
| PubMed:Effect of CRL 41034 on the adrenergic neuroeffector interaction in the canine saphenous vein. | 
| PubMed:In vitro studies of the effect of buflomedil on platelet responsiveness. | 
| PubMed:[Local intravenous treatment of algodystrophy of the hand: buflomedil versus guanethidine, long term follow-up]. | 
| PubMed:[Bencyclane in stage II arterial occlusive disease. Results of a controlled study]. | 
| PubMed:[Multi-infarct dementia. Current knowledge concerning pathogenesis and therapy]. | 
| PubMed:[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. | 
| PubMed:[Acute and chronic cerebrovascular diseases. A therapeutic approach]. | 
| PubMed:Cardiovascular actions of buflomedil and possible mechanisms involved. | 
| PubMed:Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease. | 
| PubMed:Rapid, sensitive high-performance liquid chromatographic method for the analysis of buflomedil hydrochloride and its potential by-products. | 
| PubMed:Pharmacokinetics of buflomedil after various dosage forms. | 
| PubMed:An evaluation of the ability of the peripheral vasodilator buflomedil to improve vascular patency after acute frostbite. | 
| PubMed:Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons. | 
| PubMed:The influence of buflomedil on blood viscosity parameters in insulin-dependent diabetic patients: a preliminary study. | 
| PubMed:Computer-assisted development of modified-release dosage forms. | 
| PubMed:[A study using laser-Doppler velocimetry of modifications of the labyrinthine microcirculation induced by chemical and physical stimuli]. | 
| PubMed:Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents. | 
| PubMed:[Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication]. | 
| PubMed:[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. | 
| PubMed:[Myoclonus during a course with buflomedil treatment]. | 
| PubMed:[Emetic and catalepsy-inducing actions of buflomedil]. | 
| PubMed:Effect of long-term administration of buflomedil on regional cerebral blood flow in chronic cerebral infarction. | 
| PubMed:Effect of buflomedil on cell metabolism in ischemic muscle. | 
| PubMed:[Acute severe coronary insufficiency during intravenous therapy with buflomedil hydrochloride. Description of 4 cases]. | 
| PubMed:[Acute fatal poisoning with buflomedil]. | 
| PubMed:[Decrease of blood viscosity induced by buflomedil in healthy volunteers]. | 
| PubMed:Effect of buflomedil [4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone hydrochloride] on neurotransmitters in the striatum and substantia nigra. | 
| PubMed:Gas chromatographic evaluation of buflomedil in biological samples employing the thermoionic specific detector. | 
| PubMed:[Effect of buflomedil on cerebral acetylcholine, neuroactive amino acids contents and energy metabolism: analysis using spontaneously hypertensive rat (SHR)]. | 
| PubMed:[Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil]. | 
| PubMed:[The use of buflomedil in the treatment of post-traumatic cerebral edema]. | 
| PubMed:[Effects of buflomedil on peripheral arteriopathies. An open clinical study]. | 
| PubMed:Effect of vasodilators on hepatic microcirculation: a study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liver. | 
| PubMed:[Effects of buflomedil on ambulatory activity and discrete avoidance responses in mice]. | 
| PubMed:[Nutritive skin circulation in partial ischemia: effect of various vasoactive substances]. | 
| PubMed:[Diagnostic value of intra-arterial buflomedil, during arteriography of the limbs]. | 
| PubMed:Double-blind placebo-controlled trial of buflomedil in intermittent claudication. | 
| PubMed:[Effects of buflomedil on survival rate, local cerebral blood flow and glucose utilization after cerebral ischemia in spontaneously hypertensive rats]. | 
| PubMed:[Scintigraphy with thallium-201 in the evaluation of vasoactive treatment in subjects with obliterative arteriopathies of the lower limbs]. | 
| PubMed:[Evaluation of pharmacologic treatment associated with motor-activation therapy in the prevention of senile impairment]. | 
| PubMed:Effect of buflomedil on epinephrine-enhanced platelet aggregation in vitro and ex vivo. | 
| PubMed:The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry. | 
| PubMed:Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. | 
| PubMed:[Changes in erythrocyte ATP after the oral administration of buflomedil hydrochloride]. | 
| PubMed:[Buflomedil and the speed of glycolysis. Note I]. | 
| PubMed:[Buflomedil chlorhydrate in the treatment of retinopathies]. | 
| PubMed:[Clinical picture and treatment of the Raynaud syndrome of the upper extremities]. | 
| PubMed:Vasoactive effects of buflomedil assessed by fluorescein angiography. | 
| PubMed:The pharmacological effects of buflomedil in patients with multi-cerebral infarcts dementia: an open, preliminary assessment. | 
| PubMed:[Recent drug therapy of senile dementia]. | 
| PubMed:[Buflomedil chlorhydrate in peripheral vasculopathies]. | 
| PubMed:[Study of carotid flow and cerebral circulatory impedance using Doppler computerized spectral analysis. Evaluation of the effect of buflomedil]. | 
| PubMed:[Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs]. | 
| PubMed:[Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs]. | 
| PubMed:[Buflomedil: new findings on its mechanism of action]. | 
| PubMed:Buflomedil kinetics in patients with liver disease. | 
| PubMed:[Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs]. | 
| PubMed:[Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients]. | 
| PubMed:[Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents]. | 
| PubMed:Cardiorespiratory and metabolic effects of buflomedil: case reports. | 
| PubMed:[Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study]. | 
| PubMed:[Hemorheologic therapy applications in coronary heart disease]. | 
| PubMed:Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV. | 
| PubMed:The effect of buflomedilhydrochloride (Loftyl) on temporary hearing threshold shift. | 
| PubMed:[Acute toxicity of (2,4,6-trimethoxy) phenyl-3 (pyrrolidinyl-1) propyl-ketone chlorhydrate (buflomedil) and of metacrylic copolymers (eudragit) both alone and in association in the mouse and rat]. | 
| PubMed:[Myoclonus during treatment with buflomedil]. | 
| PubMed:[Clinical evaluation of the activity of buflomedil in ischemic processes in the legs]. | 
| PubMed:[Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy]. | 
| PubMed:[Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study]. | 
| PubMed:[The combination of repeated anesthetic "bathing" of the cervico-thoracic system and buflomedil in analgesic therapy of in Raynaud's syndrome of the arm]. | 
| PubMed:[Platelet function after the single administration of buflomedil]. | 
| PubMed:[Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride]. | 
| PubMed:Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study. | 
| PubMed:[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy]. | 
| PubMed:[Stroke and post-ictal states]. | 
| PubMed:Microcirculation in the elderly. | 
| PubMed:[Use of buflomedil chlorhydrate in vertiginous patients. Vertigo]. | 
| PubMed:[Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study]. | 
| PubMed:[Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution]. | 
| PubMed:[Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil]. | 
| PubMed:[Reversible neurologic toxicity of buflomedil overdosage]. | 
| PubMed:[Effect of buflomedil on microcirculation of the skin in acral gangrene]. | 
| PubMed:Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation. | 
| PubMed:[Does conjunctival biomicroscopy enable one to assess the microcirculatory activity of buflomedil?]. | 
| PubMed:Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil. | 
| PubMed:The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids. | 
| PubMed:In-vitro effects of buflomedil on parameters regulating hemostatic balance via the prostaglandin-system. | 
| PubMed:Metabolic effects of buflomedil hydrochloride. | 
| PubMed:Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure. | 
| PubMed:Buflomedil in arterial occlusive disease: results of a controlled multicenter study. | 
| PubMed:[Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy]. | 
| PubMed:[Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study]. | 
| PubMed:[Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study]. | 
| PubMed:[Latent or evident microangiopathies in rheumatology: proposal of a pharmacologic test]. | 
| PubMed:[Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease]. | 
| PubMed:Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients. | 
| PubMed:Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study. | 
| PubMed:Our experience with the use of buflomedil chlorhydrate in a mixed population of vasculopathic patients. | 
| PubMed:Buflomedil concentrations in blood and viscera in a case of fatal intoxication. | 
| PubMed:Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies. | 
| PubMed:Cardiovascular pharmacology of buflomedil. | 
| PubMed:Effects of buflomedil on the responsiveness of canine vascular smooth muscle. | 
| PubMed:Effects of buflomedil on isolated dog arteries. | 
| PubMed:[Vasoactive drugs and microcirculation in old age]. | 
| PubMed:[Clinical pharmacokinetics of buflomedil]. | 
| PubMed:[Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies]. | 
| PubMed:[Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency]. | 
| PubMed:[Monitoring therapy in the treatment of cerebrovascular insufficiency]. | 
| PubMed:[Myoclonic encephalopathy in a patient treated with an excessive dose of buflomedil]. | 
| PubMed:[Arterio-vascular diseases. New trends in diagnosis and therapy]. | 
| PubMed:[Myoclonic encephalopathy in a patient treated with an excessive dose of buflomedil]. | 
| PubMed:[Buflomedil in the patient with renal insufficiency]. | 
| PubMed:[Buflomedil in arterial occlusive disease. Results of a controlled study]. | 
| PubMed:[Microcirculation in the conjunctiva and the nail bed in the aged. Symptomatic and clinico-pharmacologic aspects]. | 
| PubMed:[Effect of the vasoactive drug buflomedil in arterial occlusive disease]. | 
| PubMed:[Comparative vasodilator action of 5 vasodilators: dihydroergotoxine, nicergoline, papaverine, naftidrofuryl and buflomedil on the femoral artery of the dog]. | 
| PubMed:Analysis of buflomedil in mouse, rat and rabbit plasma by reversed-phase ion-pair high-performance liquid chromatography. | 
| PubMed:Buflomedil: three month intravenous safety evaluation in rats. | 
| PubMed:Improvements in the rheologic properties of blood induced by medium-term treatment with buflomedil in diabetic patients. | 
| PubMed:Protective effects of buflomedil against exercise-induced reductions in regional erythrocyte deformability of patients with peripheral arterial disease. | 
| PubMed:Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease. | 
| PubMed:[Acute poisoning by buflomedil]. | 
| PubMed:[Improved microcirculation and collateral circulation in arterial occlusive diseases of the lower extremity]. | 
| PubMed:Double blind comparative study of cinnarizine and buflomedil in patients suffering from cerebrovascular insufficiency. | 
| PubMed:Tissue pO2 and transcutaneous pO2 as guidelines in experimental and clinical drug evaluation. | 
| PubMed:Experience with buflomedil in peripheral arterial occlusive disease. | 
| PubMed:Double-blind capillaroscopic study of the activity of buflomedil in Raynaud's syndrome: a report on 80 cases. | 
| PubMed:Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency. | 
| PubMed:Effects of buflomedil on erythrocyte deformability. | 
| PubMed:Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease. | 
| PubMed:An experimental overview of a new vasoactive drug: buflomedil HCl. | 
| PubMed:Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication. | 
| PubMed:[Use of buflomedil hydrochloride in ocular pathology]. | 
| PubMed:The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration. | 
| PubMed:Pharmacokinetics of buflomedil after intravenous and oral administration. | 
| PubMed:[Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)]. | 
| PubMed:Determination of buflomedil hydrochloride [2',4',6'-trimethoxy-4-(pyrrolidinyl)butyrophenone hydrochloride] by reversed-phase ion-pair high-performance liquid chromatography. | 
| PubMed:[Assay of buflomedil in biologic media. Determination of different pharmacokinetic parameters]. |